Upstaging benefits and accuracy of sentinel lymph node mapping in colorectal adenocarcinoma nodal staging

Journal of Surgical Oncology

Volumn 98, Issue 5, 2008, Pages 324-330

  Quadros, Claudio Almeida ^a   Lopes, Ademar ^b   Araujo, Iguaracyra ^a   Fregnani, Jose Humberto ^c   Fahel, Fernanda ^a  

^a Liga Bahiana Contra o Cancer   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c Barretos Cancer Hospital   (Brazil)

Author keywords

Colon and rectal cancer; Lymphatic mapping; Micrometastasis; Neoadjuvant treatment

Indexed keywords

PHYTATE TC 99M;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; COLON ADENOCARCINOMA; COLORECTAL CARCINOMA; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; ISOTOPE TRACING; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RECTUM CARCINOMA; RISK FACTOR; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE MAPPING; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 53549108053     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21112     Document Type: Article

References (35)

1. Instituto Nacional de Cancer (INCA); Ministério da Sáude. Câncer no Brasil: dados dos registros de câncer de base populacional, vol. 1. Rio de Janeiro, 2006.
2. Cserni G: Nodal Staging of colorectal carcinomas and sentinel nodes. J Clin Pathol 2003;56:327-335.
3. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators: Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995;345:939-944.
4. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators: Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. J Clin Oncol 1999;17:1356-1363.
5. Cawthorn SJ, Gibbs NM, Marks CG: Clearance technique for the detection of lymph nodes in colorectal cancer. Br J Surg 1986;73:58-60.
6. Nelson H, Petrelli N, Carlin A, et al.: Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001;93:583-596.
7. Cianchi F, Palomba A, Boddi V, et al.: Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg 2002;26:384-389.
8. Joosten JJ, Strobbe LJ, Wauters CA, et al.: Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surgery 1999;86:482-486.
9. Kitagawa Y, Watanabe M, Hasegawa H, et al.: Sentinel node mapping for colorectal cancer with radioactive tracer. Dis Colon Rectum 2002;45:1476-1480.
10. Tsoulias GJ, Wood TF, Morton DL, et al.: Lymphatic mapping and focused analysis of sentinel nodes upstage gastrointestinal neoplasms. Arch Surg 2000;135:926-932.
11. Bilchik AJ, Nora DT, Sobin LH, et al.: Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer. J Clin Oncol 2003;21:668-672.
12. Gandy CP, Biddlestone LR, Roe AM, et al.: Intra-operative injection of patent blue V dye to facilitate nodal staging in colorectal cancer. Colorectal Dis 2002;4:447-449.
13. Merrie AE, van Rij AM, Philips LV, et al.: Diagnostic use of the sentinel node in colon cancer. Dis Colon rectum 2001;44:410-417.
14. Muslow J, Winter DC, O'Keane JC, et al.: Sentinel lymph node mapping in colorectal cancer. Br J Surg 2003;90:659-667.
15. Doekhie FS, Peeters KCMJ, Kuppen PJK, et al.: The feasibility and reliability of sentinel node mapping in colorectal cancer. EJSO 2005;31:854-862.
16. Bendavid Y, Latulippe JF, Younan RJ, et al.: Phase I on sentinel lymph node mapping in colon cancer: a preliminary report. J Surg Oncol 2002;79:81-84.
17. Saha S, Wiese D, Badin J, et al.: Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol 2000;7:120-124.
18. Trocha SD, Nora DT, Saha S, et al.: Combination probe and dye-directed lymphatic mapping detects micrometastases in early colorectal cancer. J Gastrointest Surg 2003;7:340-345.
19. Cserni G, Vajda K, Tarján M, et al.: Nodal staging of colorectal carcinomas from quantitative and qualitative aspects. Can lymphatic mapping help staging? Pathol Oncol Res 1999;5:291-296.
20. Saha S, Seghal R, Patel M, et al.: A multicenter trial of sentinel lymph node mapping in colorectal câncer: prognostic implications for nodal staging and recurrence. Am J Surg 2006;191:305-310.
21. Paramo JC, Summerall J, Wilson C, et al.: Intraoperative sentinel lymph node mapping in patients with colon cancer. Am J Surg 2001;182:40-43.
22. Tuech JJ, Pessaux P, Fiore FD, et al.: Sentinel mapping in colon cancer carcinoma: in-vivo versus ex-vivo approach. EJSO 2006;32:158-161.
23. Esser S, Reilly WT, Riley LB, et al.: The role of sentinel lymph node mapping in staging of colon and recta cancer. Dis Colon Rectum 2001;44:850-856.
24. Smith FM, Coffey JC, Khasri NM, et al.: Sentinel nodes are identifiable in formalin-fixed specimens after surgeon-performed ex vivo sentinel lymph node mapping in colorectal cancer. Ann Surg Oncol 2005;12:1-6.
25. Tuner RR, Nora DT, Trocha SD, et al.: Colorectal carcinoma staging, frequency and nature of cytokeratin-positive cells in sentinel and nonsentinel lymph nodes. Arch Pathol Lab Med 2003;127:673-679.
26. Feig BW, Curley S, Lucci A, et al.: A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg 2002;182:707-712.
27. Viehl CT, Hamel CT, Marti WR, et al.: Identification of sentinel lymph nodes in colon cancer depends on the amount of dye injected relative to tumor size. World J Surg 2003;27:1285-1290.
28. Sandrucci S, Mussa Baudolino B, Goss M, et al.: Lymphoscintigraphic localization of sentinel node in early colorectal cancer: results of a monocentric study. J Surg Oncol 2007;96:464-469.
29. Quadros CA, Lopes A, Araújo I, et al.: Retroperitoneal and lateral pelvic lymphadenectomy mapped by lymphoscintigraphy and blue dye for rectal adenocarcinoma staging. Preliminary results. Ann Surg Oncol 2006;13:1617-1621.
30. Moertel CG, Fleming TR, Macdonald JS, et al.: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-358.
31. Yasuda K, Adachi Y, Shiraishi N, et al.: Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol 2000;8:300-304.
32. Broll R, Schauer V, Schimmelpenning H, et al.: Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas. Dis Colon Rectum 1997;40:1465-1471.
33. Palma RT, Waisberg J, Bromberg SH, et al.: Micrometastasis in regional nodes of extirpated colorectal carcinoma: immunohistochemical study using anti-cytokeratin antibodies AE1/AE3. Colorectal Dis 2002;5:164-168.
34. Choi HJ, Choi YY, Hong SH: Incidence and prognostic implications of isolated tumor cells in lymph nodes patients with Dukes B colorectal carcinoma. Dis Colon Rectum 2002;45:750-756.
35. Oberg A, Stenling R, Tavelin B, et al.: Are lymph node micrometastasis of any clinical significance in Dukes stages A and B colorectal cancer? Dis Colon Rectum 1998;41:1244-1249.